Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

Volume 4, Issue 8, Page 6 (August 2009)


View previous. 12 of 44 View next.

PREVIEW

FULL TEXT

FULL-TEXT PDF (84 KB)

CITATION ALERT

CITED BY

EXPORT CITATION

EMAIL TO A COLLEAGUE

RIGHTS/PERMISSIONS

NEED REPRINTS?

Investigative Dual-PPAR Agonist Found Safe, Effective for Type 2

MARY ANN MOON

Aleglitazar, an experimental dual agonist of peroxisome proliferator-activated receptors, appeared to be safe and well tolerated in a phase II dose-finding study.

PII: S1558-0164(09)70230-5


View previous. 12 of 44 View next.

Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.